Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2021-07-09
Original market date: See footnote 1
1973-12-31
Product name:
SYNACTHEN DEPÔT
Description:
CONNUE AUSSI SOUS LE NOM DE COSYNTROPHINE
DIN:
00253952
Product Monograph/Veterinary Labelling:
Date:
2020-01-13
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ATNAHS PHARMA UK LIMITED
Sovereign House, Miles Gray Road
Basildon
ESSEX
GRANDE-BRETAGNE
SS14 3FR
Class:
Humain
Dosage form(s):
Suspension
Route(s) of administration:
Intramusculaire
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:04.00 , 36:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
H01AA02 TETRACOSACTIDE
Active ingredient group (AIG) number:See footnote5
0106365001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| Tétracosactide (Complexe tétracosactide-hydroxyde de zinc) | 1 MG / ML |